ozempic wegovy news - Search News

Ozempic reduces knee osteoarthritis pain by almost half

Can Ozempic and Wegovy help reduce knee osteoarthritis-related pain?

Medications like Ozempic and Wegovy, which are used to treat type 2 diabetes and boost weight loss, may also help reduce knee osteoarthritis-related pain in people with obesity, a trial finds.

UPI · 5d

Ozempic, Wegovy might help ease knee arthritis pain

People who received weekly injections of semaglutide -- the active agent in the diabetes drug Ozempic and the weight-loss medication Wegovy -- had a nearly 14% decrease in their body weight after 68 weeks, compared with 3% of people given a placebo, results showed. The trial was funded by Novo Nordisk, the drug company that makes semaglutide.

Health and Me on MSN · 2d

Can Ozempic Treat Arthritis Related Knee-Pain ? New Study Say Yes

Recent research has found that semaglutide injections, which also include controversial weight loss drug Ozempic, can reduce knee pain caused by obesity-related arthritis.

KXAN · 2d

Ozempic reduces knee osteoarthritis pain by almost half: Study

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss medications Ozempic and Wegovy was linked with a near halving of reported pain

FOX 5 Atlanta on MSN · 2d

Ozempic, Wegovy may help ease knee pain

A new study has found that weight loss drugs Ozempic and Wegovy have another proven benefit. Emory University's Dr. Neil Winawer sits down with Alyse Eady to examine the study's findings.

Compounded Ozempic tied to deaths, hospitalizations

U.S. News & World Report · 4h

Novo Nordisk CEO Warns of Deaths Linked to Compounded Semaglutide

Honestly, I’m quite alarmed by what we see in the U.S. now,” Novo Nordisk President and CEO Lars Fruergaard Jorgensen told CNN on Wednesday. “Patients who believe that they’re getting access to a safe product,

Becker's Hospital Review · 1h

Compounded Ozempic tied to deaths, hospitalizations: Novo Nordisk CEO

Semaglutide has been on the FDA's shortage list since 2022, which has enabled compounding pharmacies and manufactures to make their own, unapproved versions of the drug. Novo Nordisk in October requested the FDA block compounding pharmacies from producing versions of the drug, saying semaglutide is too complex for others to replicate safely.

CNN · 22h

Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths, the chief executive of Ozempic maker Novo Nordisk warned Wednesday.

Novo Nordisk posts Q3 sales of obesity drug Wegovy

CBS News on MSN · 3d

Ozempic, Wegovy sales inject wealth into Novo Nordisk home country of Denmark

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great heft to the economy of Novo Nordisk's home country, Denmark.

The Financial Times · 1d

Novo Nordisk maintains booming sales of obesity and diabetes drugs

Novo Nordisk maintained its sales growth momentum on booming sales of its weight loss and diabetes drugs, as it reported revenue and operating profit broadly in line with analysts’ expectations. The maker of the blockbuster Ozempic and Wegovy drugs has benefited in recent years from huge demand for its products.

Reuters on MSN · 1d

Novo Nordisk posts Q3 sales of obesity drug Wegovy above forecast

Novo Nordisk on Wednesday reported better-than-expected quarterly sales of its popular Wegovy weight-loss drug and narrowed its 2024 outlook for the year, in a mixed set of results reflecting growing competition in the fast-growing obesity drug market.

3don MSN

Scientist behind Novo Nordisk's Ozempic, Wegovy started her career developing laundry detergent

Novo Nordisk scientist Lotte Knudsen, whose research led to Ozempic and Wegovy, started her career developing laundry ...

22h

Ozempic/Wegovy Maker Maintains Q3 Sales Growth On Booming Demand

On Wednesday, Novo Nordisk A/S (NYSE:NVO) reported third-quarter 2024 sales of 71.311 billion Danish kroner (around $10.3 ...

Ozempic, Wegovy ingredient may lower risk of Alzheimer’s, study finds

Ever since their rise in popularity as weight loss drugs, there’s been a slew of reports on the potential adverse health ...

FiercePharma22h

After Lilly's GLP-1 sales fumble, Novo reports mixed results on Ozempic, Wegovy

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

7don MSN

Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says

It is a sign that Novo Nordisk's efforts to ramp up the supply of those drugs are starting to pay off, as demand continues to ...

3don MSN

How a love story launched the company behind Ozempic, Wegovy

Novo Nordisk, the pharma giant behind Ozempic and Wegovy, has surprising love story origins. The founders, a married couple, ...

Ozempic, Wegovy move closer to no longer being in shortage, FDA says

After years of ongoing shortages due to their growing popularity, all doses of both Ozempic and Wegovy are now listed as ...

13don MSN

Drugs like Ozempic and Wegovy are linked to a lower risk of Alzheimer’s disease, new study says

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results